SLAM
AMRX icon

Swiss Life Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Swiss Life Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Buy
21,115
+154
+0.7% +$2.11K ﹤0.01% 1139
2026
Q1 		$261K Buy
20,961
+794
+4% +$10.7K ﹤0.01% 1207
2025
Q4 		$254K Buy
+20,167
New +$231K ﹤0.01% 1126

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
WW
Westshore Wealth Newport Beach, California $322M AUM 24.46% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

Swiss Life Asset Management's AMRX Position: Q2 2026 in Review

Swiss Life Asset Management increased its Amneal Pharmaceuticals (AMRX) stake by 0.73% in Q2 2026, buying an estimated $2.11K and bringing the position to 21,115 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #1139.

Swiss Life Asset Management first reported a position in AMRX in Q4 2025 and has held it in 3 quarters since. 207 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Swiss Life Asset Management held 21,115 shares of Amneal Pharmaceuticals worth $366K as of Q2 2026.
  • Swiss Life Asset Management bought 154 Amneal Pharmaceuticals shares in Q2 2026, an estimated $2.11K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1139 holding.
  • Swiss Life Asset Management first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 207 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.